Croda Pharma is hosting a two-part topical webinar series!
Overview
Part 1: Beyond Symptom Management: Skin Barrier Repair in Psoriasis, Dermatitis & Eczema
When: Tuesday, Sept 1, 2026, 2:00-2:40 PM EST
Psoriasis, dermatitis, and eczema are all associated with impaired skin barrier function, contributing to dryness, irritation, inflammation, and increased sensitivity. As our understanding of these conditions evolves, there is growing interest in formulation strategies that not only relieve symptoms but also help restore and maintain barrier integrity.
- Learn how biomimetic ingredients and advanced delivery systems - including lanolin-derived ingredients, emollients, and liquid crystalline structures - can help restore barrier integrity, improve hydration, and reduce transepidermal water loss.
- Gain practical formulation insights for developing effective topical products for sensitive and compromised skin, with strategies that support both symptom relief and long-term skin health.
Part 2 Acne & Rosacea: Formulating for Effective Delivery and Better Tolerability
When: Thursday, Sept 17, 2026, 2:00-2:40 PM EST
Developing topical products for acne and rosacea requires balancing effective active delivery with the need to minimize irritation and support patient comfort. Challenges such as solubility, stability, skin penetration, and tolerability can significantly impact product performance and user adherence.
- Learn how formulation strategies can enhance active ingredient delivery, including the role of penetration enhancers, excipients, vehicle design, and advanced delivery systems.
- Understand the impact of formulation choices on product performance, balancing efficacy, skin feel, and tolerability to create more successful topical products.
Email the following if you have any questions: pharma.usa@croda.com or gwyn.acker@croda.com
Speakers
Dr. Yasaman Saleh is a Research Scientist at Croda Pharma, specialising in the synthesis, purification, and development of pharmaceutical excipients for drug formulation applications. She earned her Ph.D. in Organometallic Chemistry from the University of Toledo, where her research emphasised sustainable approaches to chemical synthesis and green chemistry principles. At Croda, she works on developing new excipients, improving existing materials, and evaluating opportunities to enhance the sustainability of pharmaceutical materials and processes.
.png?w=500&la=en-GB&focalpointcrop=1&xratio=1&yratio=1&hash=31426CB091DF278D5243A4FCF1069C29)
Alexandra Inglis is a Marketing Manager at Croda, leading global and regional marketing programs across the Life Sciences businesses, including Avanti Research™, Croda Pharma, and Croda Agriculture. She is passionate about bridging the gap between scientific innovation and customer value through strategic marketing, digital engagement, and compelling storytelling. Alexandra holds an MBA in Marketing Management from Pace University and brings extensive experience in product launches, brand strategy, and commercial marketing.
Title:Croda Pharma is hosting a two-part topical webinar series!
Duration:40 Minutes
Available On Demand
Thank you for registering to our topical series
Part 1: Beyond Symptom Management: Skin Barrier Repair in Psoriasis, Dermatitis & Eczema
When: Tuesday, Sept 1, 2026, 2:00-2:40 PM EST
Psoriasis, dermatitis, and eczema are all associated with impaired skin barrier function, contributing to dryness, irritation, inflammation, and increased sensitivity. As our understanding of these conditions evolves, there is growing interest in formulation strategies that not only relieve symptoms but also help restore and maintain barrier integrity.
Learn how biomimetic ingredients and advanced delivery systems—including lanolin-derived ingredients, emollients, and liquid crystalline structures—can help restore barrier integrity, improve hydration, and reduce transepidermal water loss.
Gain practical formulation insights for developing effective topical products for sensitive and compromised skin, with strategies that support both symptom relief and long-term skin health.
Part 2 Acne & Rosacea: Formulating for Effective Delivery and Better Tolerability
When: Thursday, Sept 17, 2026, 2:00-2:40 PM EST
Developing topical products for acne and rosacea requires balancing effective active delivery with the need to minimize irritation and support patient comfort. Challenges such as solubility, stability, skin penetration, and tolerability can significantly impact product performance and user adherence.
Learn how formulation strategies can enhance active ingredient delivery, including the role of penetration enhancers, excipients, vehicle design, and advanced delivery systems.
Understand the impact of formulation choices on product performance, balancing efficacy, skin feel, and tolerability to create more successful topical products.